[1] |
HUANG Ruiting, JIANG Fuqiong, HU Lingyu.
Update of diagnosis and treatment of bullous pemphigoid caused by anti-PD1/PD-L1
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(6): 461-464.
|
[2] |
ZHAO Dandan, ZHEN Li.
Analysis of the prognostic factors of bullous pemphigoid based on random forest model
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 338-343.
|
[3] |
ZHOU Xinyu, LI Fan, ZHOU Xingli, LI Wei, JIANG Xian.
Pemphigoid nodularis following COVID-19 vaccination: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 355-359.
|
[4] |
LIU Wenhong, YU Shaohua, KANG Ting, YUAN Yuan, ZHANG Renjuan, DU Hua, HE Chunfeng.
Bullous pemphigoid induced by multiple tumors was treated with PD-1 inhibitor: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 364-366.
|
[5] |
ZHU Liyun, YANG Wenhao.
Clinical feature of pediatric bullous systemic lupus erythematosus
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(3): 151-155.
|
[6] |
ZHAO Qing, ZHANG Furen.
Minocycline induced facial and hand back skin hyperpigmentation: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(1): 43-44.
|
[7] |
KONG Zelin, PI Qingyou, ZHOU Guizhi, LI Jing.
Autoimmune polyglandular syndrome type IIIC+D: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(8): 530-534.
|
[8] |
ZHAO Han, CAI Daxing.
Bullous pilomatricoma: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(6): 403-404.
|
[9] |
ZHOU Jie, LI Jiao, RU Lincheng, JIN Qianwei, GUO Yun.
Update of the effect of hydroxychloroquine on dyslipidemia and blood glucose in systemic Lupus Erythematosus patients
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(6): 405-408.
|
[10] |
CHEN Xue, TAN Cheng, SHAN Minjie, MIN Zhongsheng, JI Jin, CHEN Fang, LIU Qing, WU Hao, PAN Yongzheng.
Rituximab combined with glucocorticoid in the treatment of refractory bullous pemphigoid: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(3): 185-188.
|
[11] |
LI Min, XIA Yumin.
Clinical characteristics of male patients with systemic lupus erythematosus
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(3): 190-194.
|
[12] |
CHE Xuanlin, SU Juan, CHEN Mingliang.
Acquired hemophilia associated with bullous pemphigus: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(2): 110-111.
|
[13] |
WANG Tingting, REN Hong, HU Wenlong, KUANG Weiwei.
Drug-indruced bullous pemphigoid induced: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(11): 814-816.
|
[14] |
XIE Zhuoting, LI Anni, ZHANG Peilian.
Update of drug-associated bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(11): 833-836.
|
[15] |
SONG Pingping, YANG Baoqi.
Research advance in linear IgA bullous dermatosis
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(11): 837-841.
|